Hu, Mengnan
Bao, Ruoxuan
Lin, Miao
Han, Xiao-Ran
Ai, Ying-Jie
Gao, Yun
Guan, Kun-Liang https://orcid.org/0000-0003-1892-0174
Xiong, Yue
Yuan, Hai-Xin https://orcid.org/0000-0002-1624-3934
Article History
Received: 13 March 2022
Revised: 23 August 2022
Accepted: 24 August 2022
First Online: 5 September 2022
Competing interests
: K-LG is a co-founder of Vivace Therapeutics. YX is a co-founder of Cullgen Inc. X-RH is an employee of Cullgen (Shanghai) Inc. Other authors declare no competing financial interests.
: All animal-related procedures were performed under the Division of Laboratory Animal Medicine Regulations of Fudan University. Written informed consent was obtained from each NSCLC patient who underwent surgery at the Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China. This study was approved by the Zhongshan Hospital Research Ethics Committee (No. B2021-131).